title: Growth factors and trefoil peptides in gastrointestinal health and disease.
abstract: Peptide growth factors are a fascinating group of molecules with diverse effects. Recent developments have allowed us to gain a much greater insight into their pathophysiological functions. In addition, the development of recombinant peptide technology, monoclonal antibody production and both artificial small molecule receptor agonists and inhibitors now allows us to use these factors for the treatment of multiple conditions including gastrointestinal malignancy (particularly colonic carcinoma), short bowel syndrome (where factors such as growth hormone, epidermal growth factor and glucagons-like peptide 2 show particular promise), and inflammatory bowel disease.
authors.affiliation: Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. r.playford@imperial.ac.uk
authors.forename: Raymond J
authors.initials: RJ
authors.lastname: Playford
authors.forename: Subrata
authors.initials: S
authors.lastname: Ghosh
authors.forename: Asif
authors.initials: A
authors.lastname: Mahmood
mesh_terms: D000818:Animals; D001709:Biotechnology / Q000379:methods; D002626:Chemistry, Pharmaceutical / Q000379:methods; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000209:etiology; D041981:Gastrointestinal Tract / Q000166:cytology / Q000378:metabolism* / Q000503:physiopathology*; D006133:Growth Substances / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D009077:Mucins / Q000378:metabolism* / Q000627:therapeutic use; D009124:Muscle Proteins / Q000378:metabolism* / Q000627:therapeutic use; D010455:Peptides / Q000378:metabolism* / Q000627:therapeutic use; D013678:Technology, Pharmaceutical / Q000379:methods; D000071164:Trefoil Factor-2
chemical_list: D006133:Growth Substances; D009077:Mucins; D009124:Muscle Proteins; D010455:Peptides; D000071164:Trefoil Factor-2